Immunotherapy - PDFSEARCH.IO - Document Search Engine

Immunotherapy
Results: 985

#	Item
31	Spring Seminars 2009 Cellular therapies: insights and new horizons 16 & 17 April 2009 Amsterdam, The Netherlands Royal Tropical Institute, Amsterdam, The Netherlands Add to Reading List Source URL: www.sanquin.nl Language: English - Date: 2014-10-06 07:31:27 Immunology Lymphopoiesis Immunotherapy Cytotoxic T cell Stem cell Pluripotency Natural killer cell Regulatory T cell Alloimmunity Dendritic cell Lymphocyte T cell
32	Microsoft PowerPoint - AM0010-001 TIP Mayfinal Add to Reading List Source URL: www.armobio.com Language: English - Date: 2015-12-11 00:15:27 Immunology Immune system T cells Interleukins Programmed cell death protein 1 PD-L1 Immunotherapy CD8 IMP321 Interleukin 21
33	ISCT NA 2016 Abstract Categories Stem Cells including but not limited to:  Hematopoietic  Mesenchymal  iPSC  Tissue specific Add to Reading List Source URL: www.isct-na2016.com Language: English - Date: 2016-02-19 14:43:52 Stem cells Biotechnology Induced stem cells Gene delivery Virotherapy Gene therapy CRISPR Mesenchymal stem cell Genome engineering Viral vector Immunotherapy
34	12th International Workshop IMMUNOTHERAPY 2016: “Mapping the road for a long lasting immune-mediated control of cancer” Add to Reading List Source URL: www.immunotherapy.cim.co.cu Language: English - Date: 2015-12-17 09:23:28 Immunology Oncology Cancer treatments Cancer immunotherapy Immunotherapy Tumor microenvironment Adoptive cell transfer Cancer vaccine Cancer immunology Immune system Center of Molecular Immunology Cancer
35	VAXIMM Appoints Pharmaceutical Industry Veteran Dr. Jarl Ulf Jungnelius as Chief Medical Officer Basel (Switzerland) and Mannheim (Germany), May 18, 2016 – VAXIMM AG, a Swiss-German biotech company focused on developin Add to Reading List Source URL: www.biomedvc.com Language: English - Date: 2016-05-18 04:29:39 Oncology Cancer treatments Celgene Summit New Jersey Cancer immunotherapy Chemotherapy Ludwig Cancer Research Kite Pharma
36	PRESS RELEASE – IMMUNOCORE LIMITED Immunocore Presents Positive IMCgp100 Phase I Data at the 2016 ASCO Annual Meeting - Add to Reading List Source URL: www.immunocore.com Language: English - Date: 2016-06-06 05:18:35 Melanoma Immunology RTT Uveal melanoma Cancer immunotherapy Immunocore Uvea Tremelimumab DecisionDx-UM Adoptive cell transfer
37	Safety and Tolerability of Escalating Doses of House Dust Mite- Peptide Antigen Desensitization (HDM-PAD) Add to Reading List Source URL: www.circassia.com Language: English - Date: 2015-11-05 09:21:27 Allergology Immunology Immune system RTT Type I hypersensitivity Allergen immunotherapy Allergen Allergic conjunctivitis Allergic rhinitis Immunoglobulin E Allergy Rhinitis
38	Press Release GANYMED ANNOUNCES LICENSE OF WT1 IMMUNOTHERAPY RIGHTS BY CORIXA AND KIRIN Mainz, Germany / June 08, 2004 Ganymed Pharmaceuticals AG, Mainz, Germany, announced today that Corixa Corporation (Nasdaq: CRXA), U Add to Reading List Source URL: www.ganymed-pharmaceuticals.com Language: English - Date: 2015-02-04 05:14:56 WT1 Immunology Corixa Cancer vaccine Immunotherapy
39	ASCO Annual Meeting - Chicago, IL, May 29 –June 2, 2015; Abstract #3017 Poster #: 343 A first-in-human dose escalation study of PEGylated recombinant human IL-10 (AM0010) in advanced solid tumors. Jeffrey R. Infante1, Add to Reading List Source URL: www.armobio.com Language: English - Date: 2015-12-11 00:15:33 Immune system Immunology T cells Cancer treatments Programmed cell death protein 1 Regulatory T cell Interferon gamma Immunotherapy LAG3 Immune checkpoint CD4+ T cells and antitumor immunity Interleukin 21
40	IMMUNOTHERAPIES MOVING FORWARD COMPANY Agilvax is a biotechnology company developing targeted cancer stem cell immunotherapies and vaccines for infectious diseases. The company’s Add to Reading List Source URL: agilvax.com Language: English - Date: 2016-07-25 22:36:40 Immunology Cancer treatments Virotherapy Virus-like particle Immunotherapy Vaccine

UPDATE